Лечение хронических заболеваний суставов

1. <div><p>Breivik H., Collett B., Ventafridda V. et al. Epidemiology of chronic pain in Europe. Eur J Pain 2005; Epub ahead of print.</p><p>Pincus T., Sokka T. Abstract presented during the American College of Rheumatology 2005 Scientific Sessions. San Diego, California.</p><p>Dougados M., Gueguen A., Nguyen M. et al. Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheum 1999; 26: 855-61.</p><p>Mastbergen S.C., Bijlsma J.W.J., Lafeber F.P.E.G. Syntesis and release of human cartilage matrix proteoglycam are differently regulated by nutric oxide and prostaglandine-E2. Ann Rheum Dis 2008; 67: 52-8.</p><p>Kaplan-Machlis B., Klostermeyer B.S. The cyclooxygenase-2 inhibitors: safety and effectiveness. Ann Pharmacother 1999; 33: 979-88.</p><p>Чичасова Н.В. Лечение остеоартроза: влияние на хрящевую ткань различных противовоспалительных препаратов. РМЖ 2005; 13(8): 539-42.</p><p>Garcia-Nieto B., Perez C., Checa A. et al. Molecular model of the interaction between nimesulide and human cyclooxigenase-2. Rheumatology 1999; 38 (Suppl.): 14-8.</p><p>Shan A.A., Murray F.E., Fitzgerald D.J. The in vivo assessment of nimesulide cyclooxigenase selectivity. Rheumatology 1999; 38 (Suppl.): 19-23.</p><p>Armstrong C.P., Blower A.L. Nonsteroidal anti-inflammatory drugs and life threatening complication of peptic ulceration. Gut 1987; 28: 527-32.</p><p>Singh G., Ramey D.R., Morfield D. et al. Gastrointestinal tract complications on nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. Arch Intern Med 1996; 156: 1530-6.</p><p>Каратеев А.Е., Коновалова Н.Н., Литовченко А.А. и др. НПВП-ассоциированное заболевание желудочно-кишечного тракта при ревматизме в России. Клин. мед. 2005; 5: 33-8.</p><p>Husskisson E.C. Double-blind randomized, multicenter clinical study to evaluate the efficacy and tolerability of nimesulide vs diclofenac in patients suffering from osteoarthritis. Helsinn Healthcare 1997; 1: 36-44.</p><p>Porto A., Almedia H., Cunha M.J. et al. Double-blind evaluation by endoscopy the tolerability of nimesulide and diclofenac on gastric mucosa in osteoarhritic patients. Eur J Rheum Inflam 1994; 14: 33-8.</p><p>Mele G., Memeo A., Mellesi L. et al. Postmarkeying surveillance on nimesulide in the treatment of 8354 patients over 60 years old affected with acute and chronic musculosceletal diseases. Arch Med Int 1992: 44: 213-21.</p><p>Fusetti G., Magni E., Armandola M.C. Tolerability of nimesulide. Epidemiological data. Drugs 1993; 46 (Suppl. 1): 277—80.</p><p>Leone R., Conforti A., Chiotto E. et al. Nimesulide and renal impairment. Eur J Clin Pharmacol 1999; 55: 151-4.</p><p>Boelsterli U.A. Mechanisms of NSAID-induced hepatotoxity. Focus on nimesulide. Drug Saf 2002; 25: 633-48.</p><p>Kulkarni S. On safety of nimesulide, a preferential COX-2 inhibitor. Curr Sci 2002; 83: 1442-3.</p><p>Traversa G., Bianchi C., Da Cas R. et al. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal antiinflammatory drugs. BMJ 2003; 327: 18-22.</p><p>Балабанова Р.М., Чичасова Н.В., Цветкова Е.С. и др. Отчет о клиническом испытании препарата Найз (нимесулид) фирмы Реддик Лабораторис ЛТД при остеоартрозе. В кн.: Опыт применения препарата Найз в Российской Федерации. М., 2002; 7-8.</p><p>Маслова Е.С., Злобина Т.И., Антипова О.В. и др. Селективный НПВП Найз в лечении остеоартроза. В кн.: Опыт применения препарата Найз в Российской Федерации. М., 2002; 38—45.</p><p>Haskinsson E.C., Berry H., Gishen P. et al. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee J Rheum 1995’22: 1941-6.</p><p>Rashad S., Revell P., Hemingway A. et al. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989; 2: i: 519-22.</p><p>Mastberger S.C., Lafeber F.P., Bijlsma J.W. Selective COX-2 inhibition prevents proinflammatory cytocin-induced cartilage damage. Rheumatology 2002; 41: 801-8.</p><p>Hajjal H.E.L., Marcelis A., Devogelaer J.-P. et al. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. J Rheum 2003; 30: 2444-51.</p><p>Ruoff G. Management of pain in patients with multiple health problems: a guide for the practicing physician. Am J Med 1998; 105(1B): 53S-60S.</p><p>Graham D.J., Campen D.H., Hui R. et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005; 365: 475-81.</p><p>Johnson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Int Med 1994; 121: 289-300.</p><p>Izzo J.L., Levy D., Black H.R. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021-4.</p><p>Чичасова Н.В., Имаметдинова Г.Р., Насонов Е.Л. Возможности применения селективных ингибиторов ЦОГ 2 у больных с заболеваниями суставов и артериальной гипертензией. Науч.-практ. ревматол. 2004; 2: 37-40.</p><p>Мазуров В.И., Побегай О.В., Мартынов И.В. Отчет о результатах пилотного исследования по сравнительной оценке влияния найза (нимесулида) и диклофенака на гемодинамические показатели у больных остеоартрозом в сочетании с эссенциальной артериальной гипертензией.</p><p>Di Batista J.A., Fahmi H., He Y. et al. Differential regulation of interleukin-1-induced cyclooxigenase-2 gene expression by nimesulide in human synovial fibroblasts. Clin and Exp Rheum 2001; 19; 1(Suppl.22): S3-S5.</p><p>Mikherjee P., Rachita C., Aisen P.S. et al. Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death. Clin and Exp Rheum 2001; 19; 1(Suppl. 22): S7-S11.</p><p>Benett A., Villa G. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Exp Opin Pharmacother 2000; 1: 277-86.</p></div><br />